BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32816099)

  • 1. A potential novel therapeutic target in diabetic retinopathy: a chemokine receptor (CCR2/CCR5) inhibitor reduces retinal vascular leakage in an animal model.
    Monickaraj F; Oruganti SR; McGuire P; Das A
    Graefes Arch Clin Exp Ophthalmol; 2021 Jan; 259(1):93-100. PubMed ID: 32816099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.
    Rangasamy S; McGuire PG; Franco Nitta C; Monickaraj F; Oruganti SR; Das A
    PLoS One; 2014; 9(10):e108508. PubMed ID: 25329075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
    Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
    Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Yu YS; Min BH; Kim KW
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRP-1 Pathway Targeted Inhibition of Vascular Abnormalities in the Retina of Diabetic Mice.
    Hossain A; Tauhid L; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Ahmed SA; Bhattacharjee PS
    Curr Eye Res; 2017 Apr; 42(4):640-647. PubMed ID: 27442082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic Profiling Reveals Chemokine CXCL1 as a Mediator for Neutrophil Recruitment Associated With Blood-Retinal Barrier Alteration in Diabetic Retinopathy.
    Monickaraj F; Acosta G; Cabrera AP; Das A
    Diabetes; 2023 Jun; 72(6):781-794. PubMed ID: 36930735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
    Kim D; Mecham RP; Nguyen NH; Roy S
    Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
    Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil elastase contributes to the pathological vascular permeability characteristic of diabetic retinopathy.
    Liu H; Lessieur EM; Saadane A; Lindstrom SI; Taylor PR; Kern TS
    Diabetologia; 2019 Dec; 62(12):2365-2374. PubMed ID: 31612267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
    Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
    Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
    Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ruboxistaurin on blood-retinal barrier permeability in relation to severity of leakage in diabetic macular edema.
    Strøm C; Sander B; Klemp K; Aiello LP; Lund-Andersen H; Larsen M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3855-8. PubMed ID: 16186374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IκB kinase-β inhibitor IMD-0354 beneficially suppresses retinal vascular permeability in streptozotocin-induced diabetic mice.
    Lennikov A; Hiraoka M; Abe A; Ohno S; Fujikawa T; Itai A; Ohguro H
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6365-73. PubMed ID: 25205865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
    Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
    Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin.
    Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L
    Elife; 2020 Apr; 9():. PubMed ID: 32312382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin protects outer blood-retinal barrier in experimental diabetic retinopathy by up-regulating ZO-1 and occludin.
    Zhang C; Xie H; Yang Q; Yang Y; Li W; Tian H; Lu L; Wang F; Xu JY; Gao F; Wang J; Jin C; Xu G; Xu GT; Zhang J
    Clin Exp Ophthalmol; 2019 Dec; 47(9):1182-1197. PubMed ID: 31483932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.